Cargando…

Fast friends – Ubiquitin-like modifiers as engineered fusion partners

Ubiquitin and its relatives are major players in many biological pathways, and a variety of experimental tools based on biological chemistry or protein engineering is available for their manipulation. One popular approach is the use of linear fusions between the modifier and a protein of interest. S...

Descripción completa

Detalles Bibliográficos
Autores principales: Asimaki, Evrydiki, Petriukov, Kirill, Renz, Christian, Meister, Cindy, Ulrich, Helle D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703124/
https://www.ncbi.nlm.nih.gov/pubmed/34840080
http://dx.doi.org/10.1016/j.semcdb.2021.11.013
_version_ 1784839794816188416
author Asimaki, Evrydiki
Petriukov, Kirill
Renz, Christian
Meister, Cindy
Ulrich, Helle D.
author_facet Asimaki, Evrydiki
Petriukov, Kirill
Renz, Christian
Meister, Cindy
Ulrich, Helle D.
author_sort Asimaki, Evrydiki
collection PubMed
description Ubiquitin and its relatives are major players in many biological pathways, and a variety of experimental tools based on biological chemistry or protein engineering is available for their manipulation. One popular approach is the use of linear fusions between the modifier and a protein of interest. Such artificial constructs can facilitate the understanding of the role of ubiquitin in biological processes and can be exploited to control protein stability, interactions and degradation. Here we summarize the basic design considerations and discuss the advantages as well as limitations associated with their use. Finally, we will refer to several published case studies highlighting the principles of how they provide insight into pathways ranging from membrane protein trafficking to the control of epigenetic modifications.
format Online
Article
Text
id pubmed-9703124
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Academic Press
record_format MEDLINE/PubMed
spelling pubmed-97031242022-12-01 Fast friends – Ubiquitin-like modifiers as engineered fusion partners Asimaki, Evrydiki Petriukov, Kirill Renz, Christian Meister, Cindy Ulrich, Helle D. Semin Cell Dev Biol Article Ubiquitin and its relatives are major players in many biological pathways, and a variety of experimental tools based on biological chemistry or protein engineering is available for their manipulation. One popular approach is the use of linear fusions between the modifier and a protein of interest. Such artificial constructs can facilitate the understanding of the role of ubiquitin in biological processes and can be exploited to control protein stability, interactions and degradation. Here we summarize the basic design considerations and discuss the advantages as well as limitations associated with their use. Finally, we will refer to several published case studies highlighting the principles of how they provide insight into pathways ranging from membrane protein trafficking to the control of epigenetic modifications. Academic Press 2022-12 /pmc/articles/PMC9703124/ /pubmed/34840080 http://dx.doi.org/10.1016/j.semcdb.2021.11.013 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Asimaki, Evrydiki
Petriukov, Kirill
Renz, Christian
Meister, Cindy
Ulrich, Helle D.
Fast friends – Ubiquitin-like modifiers as engineered fusion partners
title Fast friends – Ubiquitin-like modifiers as engineered fusion partners
title_full Fast friends – Ubiquitin-like modifiers as engineered fusion partners
title_fullStr Fast friends – Ubiquitin-like modifiers as engineered fusion partners
title_full_unstemmed Fast friends – Ubiquitin-like modifiers as engineered fusion partners
title_short Fast friends – Ubiquitin-like modifiers as engineered fusion partners
title_sort fast friends – ubiquitin-like modifiers as engineered fusion partners
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703124/
https://www.ncbi.nlm.nih.gov/pubmed/34840080
http://dx.doi.org/10.1016/j.semcdb.2021.11.013
work_keys_str_mv AT asimakievrydiki fastfriendsubiquitinlikemodifiersasengineeredfusionpartners
AT petriukovkirill fastfriendsubiquitinlikemodifiersasengineeredfusionpartners
AT renzchristian fastfriendsubiquitinlikemodifiersasengineeredfusionpartners
AT meistercindy fastfriendsubiquitinlikemodifiersasengineeredfusionpartners
AT ulrichhelled fastfriendsubiquitinlikemodifiersasengineeredfusionpartners